JBIO

Jade Biosciences, Inc. Common Stock
JBIO

Overview Fund Activity

46 hedge funds and large institutions have $475M invested in Jade Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 11 closing their positions.

Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
0.73%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
10
Increased
15
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$37.9M
2
VA
2
VR Adviser
New York
$2.77M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.83M
4
LCM
4
Lynx1 Capital Management
Puerto Rico
$1.23M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$3.58M

Top Sellers

1
Norges Bank
1
Norges Bank
Norway
$0
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$4.01M
3
O
3
OrbiMed
New York
$9.35M
4
PL
4
Parkwood LLC
Ohio
$0
5
PPA
5
Parametric Portfolio Associates
Washington
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– – -15,769 Closed
CPIG
52
Chicago Partners Investment Group
Illinois
– – -14,849 Closed
Squarepoint
53
Squarepoint
New York
– – -12,941 Closed
OWP
54
Old Well Partners
North Carolina
– – -12,600 Closed
Jane Street
55
Jane Street
New York
– – -12,415 Closed
UBS Group
56
UBS Group
Switzerland
– – -484 Closed
CFGS
57
Concourse Financial Group Securities
Alabama
– – – –
EI
58
Ellevest Inc
New York
$0 13 +13 New
1 2
3